Alex Lobo | Stern IR |
Milton Werner | President & CEO |
Joseph Frattaroli | CFO |
Edward White | H.C. Wainwright |
Good morning and welcome to the Inhibikase Therapeutics First Quarter 2023 Financial Results Conference Call. All participants will be in listen-only mode. [Operator Instructions] After today’s presentation, there will be an opportunity to ask questions. [Operator Instructions] Please note, this event is being recorded.
I would now like to turn the conference over to Alexander Lobo with Stern Investor Relations.